Cruise expects production of its driverless shuttle called the Origin to begin in early 2023, according to CEO Dan Ammann.
The Origin is the Cruise’s first vehicle designed to operate without a driver.
Thus, it does not have manual controls such as a steering wheel or pedals.
Cruise’s current test fleet is comprised of hundreds of custom Chevrolet Bolt EVs equipped with driverless technology.
Cruise, a majority-owned subsidiary of General Motors, and rival Waymo have applied for permits to charge for rides and delivery using autonomous vehicles in San Francisco.
Cruise was expected to launch a ride-hailing service in San Francisco in 2019 but delayed plans to conduct further testing.
Since GM acquired Cruise in 2017, it has brought on investors such as Honda Motor, Softbank Vision Fund, Walmart, and Microsoft.
The Origin is expected to be produced by GM at its Detroit-Hamtramck plant in Michigan.


FDA Approves Mitapivat for Anemia in Thalassemia Patients
Wall Street Ends Higher as S&P 500, Nasdaq Extend Gains Ahead of Holiday Week
BOJ Minutes Reveal Growing Debate Over Interest Rate Hikes and Inflation Risks
Oil Prices Ease in Asia as Geopolitical Risks Clash With Weak Demand Outlook
RBA Signals Possible Interest Rate Hike in 2026 as Inflation Pressures Persist
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
German Exports to the U.S. Decline Sharply as Tariffs Reshape Trade in 2025
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
UK Economy Grows 0.1% in Q3 2025 as Outlook Remains Fragile
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
IMF Reaches Staff-Level Agreement With Egypt, Opening Path to $3.8 Billion in Funding
China Keeps Benchmark Lending Rates Steady as Economic Outlook Remains Cautious
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



